| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.054 | 0.3 |